Clinical Developments Suppliers In North America

Eupraxia Pharmaceuticals is a clinical-stage biotechnology company leveraging proprietary and innovative delivery technology with the goal of providing the right dose of drug in the right place for the right amount of time in indications with a high ...

Clinion provides EDC, RTSM, CTMS, eCOA and Document Automation Solutions in an Integrated, cloud-based eClinical platform. Clinion’s eClinical platform is one of industry’s most fully integrated clinical trial softwares. Clinion enables users to ...

HingeClinica is founded and managed by a team of vast experienced clinical research professionals, medical and scientific experts to render the world class clinical research services to life sciences industry and to accelerate the research right ...

We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...

NexImmune is a clinical-stage biotechnology company developing unique approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIMâ„¢) technology. AIM nanoparticles act as synthetic dendritic cells to deliver ...

Forge is developing innovative gene therapies that aim to help patients suffering from devastating rare diseases. Forge is building capacity to directly address the growing demand for gene therapy manufacturing. Forge is currently building the ...

INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...

Founded in 2008, S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain. ...

Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...

Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...

Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. At Tonix, we are focused on ...

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...

BacVax, Inc., a Delaware corporation with headquarters in Phoenix, Arizona, is developing vaccines against bacteria. BacVax holds an Exclusive Patent License Agreement to use the BVP platform in conjunction with additional patent applications ...

At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. ...

Covalon Technologies Ltd. (Covalon) develops and commercializes proprietary technologies for major medical device manufacturers. Our partners include the top medical device companies, leaders in urology, wound care, vascular access, venture capital, ...

DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services, including clinical trials and regulatory services, specializing in the development of custom assays, consumables, and instruments for point-of-use applications. ...

XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our ...

ivWatch was established with the mission to eliminate the harm done by IV infiltrations and extravasations to help improve patient outcomes. At ivWatch, we believe that by working together, we can enhance patient safety, advance patient care, and ...

SonALAsense’s ALA sonodynamic therapy (SDT) is well differentiated from the use of other forms of therapy which have been used for GBM or rGBM. Our use of a MRI-guided focused ultrasound device with ALA is a true drug-device combination, where both ...

Turing Medical specializes in enhancing neuromodulation therapies through the integration of personalized, precise image-based targeting into clinical workflows. Their automated processes aim to deliver patient-specific targeting, optimizing ...